Equitable Trust’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,280
Closed -$475K 461
2025
Q1
$475K Hold
21,280
0.03% 314
2024
Q4
$367K Hold
21,280
0.02% 383
2024
Q3
$357K Buy
21,280
+5,205
+32% +$125K 0.02% 370
2024
Q2
$460K Hold
16,075
0.03% 313
2024
Q1
$613K Buy
16,075
+2,671
+20% +$101K 0.04% 267
2023
Q4
$498K Sell
13,404
-248
-2% -$8.33K 0.04% 278
2023
Q3
$464K Sell
13,652
-2,088
-13% -$78.8K 0.04% 267
2023
Q2
$619K Hold
15,740
0.05% 236
2023
Q1
$506K Sell
15,740
-1,910
-11% -$63.1K 0.04% 250
2022
Q4
$550K Sell
17,650
-11,909
-40% -$431K 0.04% 246
2022
Q3
$1.09M Sell
29,559
-1,507
-5% -$56.4K 0.09% 160
2022
Q2
$902K Buy
31,066
+21,249
+216% +$761K 0.07% 190
2022
Q1
$505K Buy
+9,817
New +$420K 0.03% 248

Other funds holding PGNY

Equitable Trust's PGNY Position: Q2 2025 in Review

Equitable Trust sold out of Progyny (PGNY) in Q2 2025, closing a stake of 21,280 shares — an estimated $475K sold.

Equitable Trust first reported a position in PGNY in Q1 2022 and held it in 13 quarters. The position peaked at $1.09M in Q3 2022. 302 funds tracked by Wall St. Rank hold PGNY as of Q2 2025.

  • Equitable Trust reported no remaining Progyny position as of Q2 2025 after selling out during the quarter.
  • Equitable Trust sold 21,280 Progyny shares in Q2 2025, an estimated $475K.
  • Equitable Trust first reported a position in Progyny in Q1 2022 and held it in 13 quarters.
  • Equitable Trust's Progyny position peaked at $1.09M in Q3 2022.
  • 302 funds tracked by Wall St. Rank held Progyny as of Q2 2025.

Based on Equitable Trust's 13F filing for Q2 2025, filed 23 Jul 2025.